Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Active-controlled, Randomized, Three-cycle, Crossover Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of Single-Dose THDB0206 Injection in Healthy Chinese Subjects

NCT06153329 is registered in ClinicalTrials.gov with Tonghua Dongbao Pharmaceutical Co.,Ltd as lead sponsor.

NCT NCT06153329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06153329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Active-controlled, Randomized, Three-cycle, Crossover Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of Single-Dose THDB0206 Injection in Healthy Chinese Subjects
Lead sponsor
Tonghua Dongbao Pharmaceutical Co.,Ltd
Phase
Phase 1
Overall status
Completed
Start date
June 17, 2021
Completion date
June 6, 2022
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy